Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB-ABBS Cause Swollen joint count increased? 29 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Swollen joint count increased have been filed in association with RITUXIMAB-ABBS. This represents 0.7% of all adverse event reports for RITUXIMAB-ABBS.

29
Reports of Swollen joint count increased with RITUXIMAB-ABBS
0.7%
of all RITUXIMAB-ABBS reports
22
Deaths
23
Hospitalizations

How Dangerous Is Swollen joint count increased From RITUXIMAB-ABBS?

Of the 29 reports, 22 (75.9%) resulted in death, 23 (79.3%) required hospitalization, and 27 (93.1%) were considered life-threatening.

Is Swollen joint count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB-ABBS Cause?

Off label use (2,167) Intentional product use issue (273) Dyspnoea (208) Pain (205) Rheumatoid arthritis (202) Intentional dose omission (196) Fatigue (195) Drug ineffective (186) Hypertension (183) Infusion related reaction (183)

What Other Drugs Cause Swollen joint count increased?

METHOTREXATE (2,068) ABATACEPT (2,032) TOCILIZUMAB (1,987) RITUXIMAB (1,973) ADALIMUMAB (1,933) DICLOFENAC (1,916) LEFLUNOMIDE (1,907) FOLIC ACID (1,898) PREDNISONE (1,882) ALENDRONATE (1,880)

Which RITUXIMAB-ABBS Alternatives Have Lower Swollen joint count increased Risk?

RITUXIMAB-ABBS vs RITUXIMAB-ARRX RITUXIMAB-ABBS vs RITUXIMAB-PVVR RITUXIMAB-ABBS vs RIVAROXABAN RITUXIMAB-ABBS vs RIVASTIGMINE RITUXIMAB-ABBS vs RIVOTRIL

Related Pages

RITUXIMAB-ABBS Full Profile All Swollen joint count increased Reports All Drugs Causing Swollen joint count increased RITUXIMAB-ABBS Demographics